Publications by authors named "David Lally"

Background: Intestinal schistosomiasis was confirmed endemic in Mangochi District, Malawi, in May of 2018 following an unexpected encounter with discreet populations of Biomphalaria spp. freshwater snails during routine malacological surveillance activities. Since then, only limited malacological surveillance of Biomphalaria has been carried out, and so the distribution of Biomphalaria populations in this area is currently unclear.

View Article and Find Full Text PDF

To shed first light on caprine schistosomiasis and its zoonotic potential in Malawi, we conducted a molecular epidemiological investigation, sampling goats ( = 230) across three districts, using faecal miracidia hatching test. Molecular genotyping of miracidia later revealed the prevalence of to be 0.0 % in Nsanje District ( = 30), 16.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied intestinal schistosomiasis caused by Schistosoma mansoni in children living along the southern shoreline of Lake Malawi, five years after a disease outbreak, using advanced diagnostic techniques.
  • They utilized various methods including microscopy and real-time PCR on fecal and urine samples to assess infection rates and found that the prevalence of S. mansoni varied greatly based on the diagnostic tool used.
  • The study highlighted that while fecal-egg microscopy had very low sensitivity, the point-of-care test showed moderate sensitivity depending on how results were interpreted, also revealing notable DNA presence of another species, S. haematobium, in the samples.
View Article and Find Full Text PDF
Article Synopsis
  • A study in Malawi found a high prevalence of bovine schistosomiasis in cattle, with around 49.1% infected based on a miracidia hatch test, though there were notable differences in infection rates across different areas.
  • In a specific herd near Lake Malawi, researchers used GPS tracking to monitor infection levels, discovering that while treatment was initially effective, reinfection occurred, especially in younger cattle.
  • The findings highlight the need for a One Health approach to control schistosomiasis, addressing the interconnected issues of human and animal health, particularly in the context of zoonotic disease transmission in areas like Mangochi District.
View Article and Find Full Text PDF

Purpose: To evaluate safety and tolerability of EYP-1901, an intravitreal insert containing vorolanib, a pan-VEGF receptor inhibitor packaged in a bioerodible delivery technology (Durasert E™) for sustained delivery, in patients with wet age-related macular degeneration (wAMD) previously treated with anti-VEGF therapy.

Design: Phase I, multicenter, prospective, open-label, dose-escalation trial.

Participants: Patients with wAMD and evidence of prior anti-VEGF therapy response.

View Article and Find Full Text PDF

Purpose: Disparities in clinical trials are a major problem because of significant underrepresentation of certain gender, racial, and ethnic groups. Several factors including stringent eligibility criteria and recruitment strategies hinder our understanding of retinal disease. Thus, we aimed to study the various reasons of screen failures and specific patient and study characteristics among screen failures.

View Article and Find Full Text PDF
Article Synopsis
  • - The GATHER trials aimed to assess how reducing geographic atrophy (GA) lesion growth affects visual acuity, using randomized, double-masked, and sham-controlled methods with participants aged 50 or older.
  • - In these trials, patients were randomized to receive either 2 mg of avacincaptad pegol (ACP) or a sham treatment, with results showing a lower percentage of vision loss in those treated with ACP at 12 months compared to the sham group.
  • - The study concluded that ACP 2 mg treatment effectively delayed the progression of vision loss and maintained eligibility for driving in patients compared to those receiving sham treatment.
View Article and Find Full Text PDF

Schistosomiasis is a neglected tropical disease (NTD) caused by infection with parasitic trematodes of the genus that can lead to debilitating morbidity and mortality. The World Health Organization recommend molecular xenomonitoring of spp. freshwater snail intermediate hosts of to identify highly focal intestinal schistosomiasis transmission sites and monitor disease transmission, particularly in low-endemicity areas.

View Article and Find Full Text PDF

Background: Geographic atrophy is a leading cause of progressive, irreversible vision loss. The objectives of OAKS and DERBY were to assess the efficacy and safety of pegcetacoplan compared with sham treatment in patients with geographic atrophy.

Methods: OAKS and DERBY were two 24-month, multicentre, randomised, double-masked, sham-controlled, phase 3 studies, in which patients aged 60 years and older with geographic atrophy secondary to age-related macular degeneration were enrolled at 110 clinical sites and 122 clinical sites worldwide, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Geographic atrophy is a severe type of dry age-related macular degeneration that can cause significant vision loss, and this study evaluates the safety and effectiveness of avacincaptad pegol 2 mg in slowing its progression.
  • The GATHER2 trial was a comprehensive, double-masked, sham-controlled study conducted over 24 months, involving 448 participants aged 50 and older, divided into two groups receiving either the treatment or a sham injection.
  • Results showed a significant reduction in the growth of geographic atrophy lesions in patients receiving avacincaptad pegol compared to those who received the sham treatment over 12 months.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the safety and effectiveness of avacincaptad pegol (ACP), a C5 inhibitor, for treating geographic atrophy (GA) related to age-related macular degeneration (AMD) over an 18-month period.
  • In a phase 2/3 clinical trial, 286 participants were split into groups to receive monthly injections of either ACP at different dosages or sham treatment, measuring GA progression with fundus autofluorescence.
  • Results indicated that both ACP dosages significantly reduced GA growth compared to sham treatment, with mostly mild adverse effects; ongoing research (GATHER2 trial) is planned to further assess ACP's treatment potential.
View Article and Find Full Text PDF

Purpose: To report a case of central retinal vein occlusion in a young patient after the use of amyl nitrate "poppers."

Methods: Description of the patient's clinical history, ophthalmic examination, retinal imaging, and treatment.

Results: A 38-year-old man presented with a central retinal vein occlusion in his right eye after inhaling amyl nitrite "poppers.

View Article and Find Full Text PDF

Purpose: To compare identification rates of retinal fluid of the Notal Vision Home Optical Coherence Tomography (OCT) device (NVHO) when used by people with age-related macular degeneration (AMD) to those captured by a commercial OCT.

Methods: Prospective, cross-sectional study where patients underwent commercial OCT imaging followed by self-imaging with either the NVHO 2.5 or the NVHO 3 in clinic setting.

View Article and Find Full Text PDF

Objective: To determine the effect of subretinal fluid (SRF) resolution on visual acuity in patients with neovascular age-related macular degeneration (nAMD) from the HARBOR trial.

Design: Post hoc analysis of the HARBOR trial (a phase 3, double-masked, randomized, active treatment-controlled trial of ranibizumab conducted between July 2009 and August 2012 [NCT00891735]) was carried out from January 2020 to July 2021.

Participants: Treatment-naive patients with nAMD and active subfoveal choroidal neovascularization (N = 1097).

View Article and Find Full Text PDF

Objective: Post-hoc analysis to compare the outcomes of brolucizumab 6 mg vs. aflibercept 2 mg in neovascular age-related macular degeneration (nAMD) patients with early persistent retinal fluid in HAWK and HARRIER.

Methods: After 3 monthly loading doses, brolucizumab-treated eyes (N = 730) received injections every 12 weeks (q12w) or q8w if disease activity was detected.

View Article and Find Full Text PDF

Diarrhoeal disease remains a leading cause of death in children in sub-Saharan Africa, attributed to environmental health factors such as inadequate water, sanitation and hygiene (WASH) and food hygiene. This formative study in low-income areas of Blantyre focussed on the practices in Early Childhood Development Centre (ECDCs) environments where children spend a significant amount of time. A mixed-methods approach was applied to identify key hygiene behaviours in ECDCs through; checklist and structured observations ( = 849 children; n = 33 caregivers), focus group discussions (= 25) and microbiological sampling ( = 261) of drinking water, food handler's hands, and eating utensils.

View Article and Find Full Text PDF

Peripherin-2 (PRPH2) gene variants are a well-established cause of multiple inherited maculopathies including central areolar choroidal dystrophy (CACD) and pattern dystrophy. In this familial case study, we present a 63-year-old proband who presented with visual acuity of 20/63 right eye and 20/100 left eye with a complaint of lowered visual acuity in the left eye for unknown duration. Fundus examination presented with unifocal atrophic lesions bilaterally.

View Article and Find Full Text PDF

Purpose: To evaluate a patient with multiple evanescent white dot syndrome with multimodal imaging including high-resolution spectral-domain optical coherence tomography.

Methods: The patient was evaluated with wide-field color and autofluorescence imaging, microperimetry, and near-infrared imaging. Spectral-domain optical coherence tomography was performed using an instrument capable of 3- μ m axial resolution, the high-resolution Heidelberg Spectralis.

View Article and Find Full Text PDF

Importance: Outcome data are limited regarding early experience with brolucizumab, the most recently approved anti-vascular endothelial growth factor (VEGF) agent for the treatment of neovascular age-related macular degeneration (nAMD).

Objective: To report clinical outcomes after intravitreous injection (IVI) of brolucizumab, 6 mg, for nAMD.

Design, Setting, And Participants: This retrospective case series conducted at 15 private or academic ophthalmological centers in the United States included all consecutive patients with eyes treated with brolucizumab by 6 retina specialists between October 17, 2019, and April 1, 2020.

View Article and Find Full Text PDF

Background: Intestinal schistosomiasis was not considered endemic in Lake Malawi until November 2017 when populations of Biomphalaria pfeifferi were first reported; in May 2018, emergence of intestinal schistosomiasis was confirmed. This emergence was in spite of ongoing control of urogenital schistosomiasis by preventive chemotherapy. Our current study sought to ascertain whether intestinal schistosomiasis is transitioning from emergence to outbreak, to judge if stepped-up control interventions are needed.

View Article and Find Full Text PDF

Neoplasms of the retinal pigment epithelium (RPE) are rare tumors that can simulate choroidal melanoma, but clinical and imaging characteristics often differentiate these lesions. We report a 70-year-old male with an abruptly elevated pigmented lesion that arose at the site of congenital hypertrophy of the RPE and demonstrated associated exudation, as well as feeding and draining vessels, suggestive of RPE adenoma. Optical coherence tomography showed retinal elevation with serous retinal detachment adjacent to the mass, and ultrasonography revealed an abruptly elevated, moderately echodense mass of 6.

View Article and Find Full Text PDF

Purpose: To determine whether small macular hole closure can be achieved with 25-G vitrectomy surgery with internal limiting membrane peeling without the use of intraocular gas tamponade or facedown positioning.

Methods: 25-G vitrectomy surgery with internal limiting membrane peeling without the use of intraocular gas tamponade or positioning was performed on 20 eyes with a small (<400-µm diameter), full-thickness macular hole.

Results: In 17 of 20 eyes (85%), the hole had closed.

View Article and Find Full Text PDF